Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma.

导出 OA

翻译打印收藏纠错

作者： Se Ik,Kim ^[1] ; Suhyun,Hwangbo ^[2] ; Kisoon,Dan ^[3] ; Hee Seung,Kim ^[1] ; Hyun Hoon,Chung ^[1] ; Jae-Weon,Kim ^[1] ; Noh Hyun,Park ^[1] ; Yong-Sang,Song ^[1] ; Dohyun,Han ^[4] ; Maria,Lee ^[5]

作者单位： Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea. ^[1] Department of Genomic Medicine, Seoul National University Hospital, Seoul, Republic of Korea. ^[2] Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. ^[3] Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: hdh03@snu.ac.kr. ^[4] Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: marialeemd@gmail.com. ^[5]

关键词 enzyme-linked immunosorbent assay high-grade serous carcinoma ovarian neoplasms prognosis proteomics